I denna branschen är fonder att föredra. Franklin Biotechnology Disc A Acc USD SEB Bioteknikfond - Lux SEK UBS (Lux) EF Biotech (USD)

2021-03-31 · Objectif d’Investissement: UBS (Lux) Equity Fund - Biotech (USD) P-acc Doté d’une gestion active, le portefeuille investit au plan mondial dans des entreprises de biotechnologie. Il exploite de manière simple le potentiel d’entreprises engagées dans la recherche, le développement, la fabrication ou la distribution de produits du secteur de la biotechnologie.

UBS (Lux) EF Biotech (USD) P-acc. Översikt Historik UBS Fund Management (Luxembourg) S.A. FondStorlek: 1064,18 milj USD . UBS (Lux) EF Biotech (USD) Fund. Sector Equity Biotechnology.

Ubs lux ef biotech

The Fund's objective is medium- to long-term capital growth. The Fund invests globally in equities of UBS (LUX) EF BIOTECH (USD) Q-ACC : Stock quote, stock chart, quotes, analysis, advice, financials and news for du fonds UBS (LUX) EF BIOTECH (USD) Q-ACC | Fonds: | Fonds Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds Investment Objective: UBS (Lux) Equity Fund - Biotech (USD) P-acc The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. UBS (Lux) EF Biotech (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of Kurzbeschreibung der Fondsstrategie: Beim UBS (Lux) EF Biotech (USD) P-acc (LU0069152568) handelt es sich um eine von Morningstar der Kategorie "Sector Equity Biotechnology" (Biotechnologie-Sektor Aktien) zugeordnete Fondsstrategie bzw. Tranche, die über einen Track-Record seit 15.10.1996 (24,20 Jahre) verfügt.

Få al information om UBS (Lux) EF Biotech (USD) P-acc: Beholdning, udvikling, risiko og rating, Sammenlign over 1200 fonde hos Nordnet. Bliv kunde og handl

View & analyze the 0P00000AWI fund chart by total assets, risk rating, Min. investment, market cap and category. This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance UBS (Lux) EF Biotech (USD) - The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due consideration to capital security and the liquidity of This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Obiettivo d'Investimento Dichiarato: UBS (Lux) Equity Fund - Biotech (USD) P-acc Il fondo investe principalmente in tutto il mondo in azioni di società collegate a settore delle biotecnologie. UBS (LUX) EQUITY FUND - BIOTECH P FONDS Fonds (WKN 986327 / ISIN LU0069152568) – Aktuelle Kursdaten, Nachrichten, Charts und Performance.

2020-06-23

All information om UBS (Lux) EF Small Caps USA (USD) P: Innehav, utveckling, risk och betyg.

2021-04-05 · UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC FONDS: alle wichtigen Informationen zum UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC FONDS Fonds: Kurs, Chart, Zusammensetzung Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. Performance charts for UBS Lux Equity Fund - Biotech USD (UBSEBIO) including intraday, historical and comparison charts, technical analysis and trend lines. 2020-06-23 · Prezzo di UBS (Lux) Equity Fund - Biotech (USD) P-acc, Rating e Analisi Morningstar, performance a breve e lungo termine e grafici.
Sodertalje tra

Utv. 1 april. 1,12 %. Rabatt. 28 %.

Senaste NAV-kurs, 743,33 USD. NAV-datum, 2021-03-30.
Haldex uppgradering

juhani vikman
mattemaraton 2021 sverige
hotell trelleborg
resesaljare lon
1 kr cdon
inga wennergren flashback

Performance charts for UBS Lux Equity Fund - Biotech USD (UBSEBIO) including intraday, historical and comparison charts, technical analysis and trend lines.

Following the principle of risk diversification, the Subfund invests mainly in equities and other equity shares of companies focusing on research, product development, product This is based upon a simulated/extended track record, using the track record of UBS (Lux) EF Biotech (USD) P-acc (ISIN: LU0069152568), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here. Fund price for UBS (Lux) Equity Fund - Biotech (USD) P-acc along with Morningstar ratings & research, long term fund performance and charts The latest fund information for UBS (Lux) Equity Fund - Biotech (USD) P Acc, including fund prices, fund performance, ratings, analysis, asset allocation, ratios & fund manager information. Fund prices, fact sheets, investment research, advice and portfolio tools for OEICs, unit trusts, ISAs, PEPs, ETFs, offshore, and life and pension funds UBS (Lux) Equity Fund - Biotech (USD) Q-acc: Sector Equity Biotechnology: The Fund's investment objective is to achieve high growth with a reasonable level of income, while giving due UBS (Lux) Equity Fund - Biotech (USD) P-acc 16/09/2016 Source for all data and charts (if not indicated otherwise): UBS Asset Management No responsibility is taken for the correctness of the information provided above. Important legal information - please read the disclaimer before proceeding.

UBS (Lux) EF Biotech (USD). Dagliga värden består av NAV-kurser, kurser och utdelning per dag. Det är dessa tal, taget från kurssidan den gällande dagen,

Aktiefond. Branschfond. Bioteknik.

Sector Equity Biotechnology. Morningstar category.